SoftGenetics

SoftGenetics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2000, SoftGenetics has established itself as a specialized provider of analytical software for genetics and genomics. The company's core business is a portfolio of software tools, including NextGENe® for sequencing analysis and GeneMarker® for fragment analysis, which enable researchers and forensic labs to analyze complex genetic data with speed and accuracy. It operates a platform-plus-products model, offering both a unifying scientific R&D platform (Luma) and standalone point solutions, generating revenue through software licensing and subscriptions. As a private company, it focuses on expanding its AI-powered automation capabilities to capture a larger share of the growing bioinformatics and computational biology market.

Genetics & GenomicsDiagnostics

Technology Platform

Luma scientific intelligence platform for AI-powered data management and workflow automation, plus a suite of specialized software for genetic sequencing analysis, fragment analysis, forensic DNA analysis, bioinformatics, proteomics, and electronic lab notebook functions.

Opportunities

The explosion of multi-omics data and the need for integrated analysis tools creates a significant opportunity for its Luma platform.
The ongoing digital transformation of laboratories drives demand for workflow automation and electronic lab notebook solutions.
Expansion in clinical diagnostics and international forensic markets offers avenues for growth.

Risk Factors

Faces intense competition from large, integrated life science tools companies and open-source software communities.
Rapid technological change in sequencing and analytical methods requires constant, costly R&D to avoid obsolescence.
Revenue dependence on forensic and clinical markets subjects the company to regulatory validation cycles and public sector budget constraints.

Competitive Landscape

SoftGenetics competes in a fragmented but competitive market. It faces large, diversified competitors like Illumina (DRAGEN), Thermo Fisher, and QIAGEN in NGS analysis, and other specialized software vendors like DNASTAR, Partek, and Golden Helix. In forensics, it competes with Promega's GeneMapper and other accredited software. Its platform strategy also brings it into competition with ELN and informatics providers like Benchling and BioVia.